𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells

✍ Scribed by Naohiko Koshikawa; Hiroto Mizushima; Tomoko Minegishi; Fuyuki Eguchi; Fusanori Yotsumoto; Kazuki Nabeshima; Shingo Miyamoto; Eisuke Mekada; Motoharu Seiki


Book ID
108586900
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
611 KB
Volume
102
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Induction of heparin-binding EGF-like gr
✍ Faye M. Johnson; Babita Saigal; Nicholas J. Donato πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 459 KB

Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases. Inhibition of BCR-ABL and c-kit accounts for its clinical activity in leukemia and sarcoma, respectively. In this report, we describe other cellular targets for imatinib.

Regulation of matrix metalloproteinase-2
✍ Ryouichi Hamasuna; Hiroaki Kataoka; Takuzou Moriyama; Hiroshi Itoh; Motoharu Sei πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 292 KB πŸ‘ 2 views

Hepatocyte growth factor/scatter factor (HGF/SF) contributes to the malignant progression of human gliomas. We investigated the effect of HGF/SF on matrix metalloproteinase-2 (MMP-2), membrane type 1 matrix metalloproteinase (MT1-MMP) and tissue inhibitors of metalloproteinases (TIMPs), expressions